Incidence of Conjunctivitis and Other Ocular Surface Disorders in Patients With Long-Term Dupilumab Use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of Conjunctivitis and Other Ocular Surface Disorders in Patients With Long-Term Dupilumab Use

Published:2020-05-25 Issue:5 Volume:24 Page:527-528
ISSN:1203-4754
Container-title:Journal of Cutaneous Medicine and Surgery
language:en
Short-container-title:J Cutan Med Surg

Author:

Jo Christine E.¹^ORCID,Georgakopoulos Jorge R.²^ORCID,Drucker Aaron M.²³,Piguet Vincent²³,Yeung Jensen²³⁴⁵

Affiliation:

1. Faculty of Medicine, University of Ottawa, ON, Canada

2. Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada

3. Division of Dermatology, Department of Medicine, Women’s College Hospital, Toronto, ON, Canada

4. Sunnybrook Health Sciences Centre, Toronto, ON, Canada

5. Probity Medical Research Inc., Waterloo, ON, Canada

Publisher

SAGE Publications

Subject

Dermatology,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/1203475420929920

Reference5 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Dual Inhibition of IL-12/IL-23 and Selective Inhibition of IL-23 in Psoriasis

3. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

4. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab–clinical characteristics and treatment

5. Diagnosis and Management of Conjunctivitis for the Dermatologist

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab-induced ocular surface disease: a primer;Drug and Therapeutics Bulletin;2023-07-03

2. Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting;Australasian Journal of Dermatology;2022-09-20

3. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND);Journal of the American Academy of Dermatology;2022-08

4. Dupilumab-induced ocular surface disease: a primer;BMJ Case Reports;2022-04

5. Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases;Clinical Reviews in Allergy & Immunology;2022-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3